{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T08:07:10Z","timestamp":1790842030365,"version":"4.1.0"},"reference-count":36,"publisher":"Informa UK Limited","issue":"9","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Biological Therapy"],"published-print":{"date-parts":[[2022,9,2]]},"DOI":"10.1080\/14712598.2022.2060737","type":"journal-article","created":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T06:13:34Z","timestamp":1649052814000},"page":"1067-1071","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":157,"title":["Addressing high dose AAV toxicity \u2013 \u2018one and done\u2019 or \u2018slower and lower\u2019?"],"prefix":"10.1080","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2811-1410","authenticated-orcid":false,"given":"Takashi Kei","family":"Kishimoto","sequence":"first","affiliation":[{"name":"Selecta Biosciences, Watertown, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7299-9608","authenticated-orcid":false,"given":"Richard Jude","family":"Samulski","sequence":"additional","affiliation":[{"name":"Gene Therapy Center and Department of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2022,4,3]]},"reference":[{"key":"cit0001","unstructured":"Food and Drug Administration (FDA) Cellular, Tissue, and Gene Therapies Advisory Committee (CTGTAC) meeting #70 brief document. [cited 2022 Feb 25]. Available from: www.fdagov\/media\/151599\/download"},{"key":"cit0002","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtm.2017.11.007"},{"key":"cit0003","doi-asserted-by":"publisher","DOI":"10.1089\/hum.2020.29117.trf"},{"key":"cit0004","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1108046"},{"key":"cit0005","doi-asserted-by":"publisher","DOI":"10.1089\/gen.40.09.04"},{"key":"cit0006","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00670"},{"key":"cit0007","doi-asserted-by":"publisher","DOI":"10.1172\/JCI143780"},{"key":"cit0008","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.2500"},{"key":"cit0009","author":"Philippidis A","year":"2021","journal-title":"Genet Eng Biotechnol News"},{"key":"cit0010","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2020.11.054"},{"key":"cit0011","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2020.12.007"},{"key":"cit0012","first-page":"804","volume":"20","author":"Mullard A","year":"2021","journal-title":"Nature"},{"key":"cit0013","unstructured":"[cited 2022 Feb 25]. https:\/\/www.cureduchenne.org\/partner-news\/a-message-from-pfizer-on-our-dmd-clinical-program\/"},{"key":"cit0014","unstructured":"[cited 2022 Feb 25]. https:\/\/endpts.com\/one-of-pfizers-duchenne-gene-therapy-trials-put-on-hold-in-wake-of-patient-death-as-high-dose-aav-concerns-still-cloud-field\/"},{"key":"cit0015","doi-asserted-by":"publisher","DOI":"10.1038\/sj.gt.3301541"},{"key":"cit0016","doi-asserted-by":"publisher","DOI":"10.1172\/JCI79213"},{"key":"cit0017","doi-asserted-by":"publisher","DOI":"10.1089\/hum.2020.167"},{"key":"cit0018","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-020-0741-7"},{"key":"cit0019","unstructured":"[cited 2022 Feb 25]. http:\/\/uniqure.com\/PR_HCC%20Investigation%20Findings%20_3_29_21_FINAL.pdf"},{"key":"cit0020","unstructured":"[cited 2022 Feb 25]. https:\/\/investors.biomarin.com\/2021-09-06-U-S-FDA-Placed-a-Clinical-Hold-on-BMN-307-Phearless-Phase-1-2-Gene-Therapy-Study-in-Adults-with-PKU-Based-on-Interim-Pre-clinical-Study-Findings"},{"key":"cit0021","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aba9188"},{"key":"cit0022","doi-asserted-by":"publisher","DOI":"10.1089\/hum.2018.015"},{"key":"cit0023","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.675897"},{"key":"cit0024","unstructured":"[cited 2022 Feb 25]. https:\/\/investorrelations.sarepta.com\/news-releases\/news-release-details\/sarepta-therapeutics-srp-9001-shows-sustained-functional"},{"key":"cit0025","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0802866105"},{"key":"cit0026","doi-asserted-by":"publisher","DOI":"10.1038\/s41576-019-0205-4"},{"key":"cit0027","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1708538"},{"key":"cit0028","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2011.108"},{"key":"cit0029","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-0911-7"},{"key":"cit0030","doi-asserted-by":"publisher","DOI":"10.1172\/JCI122372"},{"key":"cit0031","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtm.2019.05.009"},{"key":"cit0032","doi-asserted-by":"publisher","DOI":"10.1089\/humc.2015.068"},{"key":"cit0033","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06621-3"},{"key":"cit0034","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.637469"},{"key":"cit0035","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29176"},{"key":"cit0036","doi-asserted-by":"publisher","DOI":"10.3109\/03014460.2013.807878"}],"container-title":["Expert Opinion on Biological Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14712598.2022.2060737","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T05:47:57Z","timestamp":1672811277000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14712598.2022.2060737"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,3]]},"references-count":36,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9,2]]}},"alternative-id":["10.1080\/14712598.2022.2060737"],"URL":"https:\/\/doi.org\/10.1080\/14712598.2022.2060737","relation":{},"ISSN":["1471-2598","1744-7682"],"issn-type":[{"value":"1471-2598","type":"print"},{"value":"1744-7682","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,3]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iebt20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iebt20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2022-01-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-03-29","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-04-03","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}